DOI QR코드

DOI QR Code

Refractory Clostridium difficile Infection Cured With Fecal Microbiota Transplantation in Vancomycin-Resistant Enterococcus Colonized Patient

  • Jang, Mi-Ok (Department of Internal Medicine, Chonnam National University Medical School) ;
  • An, Jun Hwan (Department of Internal Medicine, Chonnam National University Medical School) ;
  • Jung, Sook-In (Department of Internal Medicine, Chonnam National University Medical School) ;
  • Park, Kyung-Hwa (Department of Internal Medicine, Chonnam National University Medical School)
  • Received : 2013.11.12
  • Accepted : 2014.04.04
  • Published : 2015.01.31

Abstract

The rates and severity of Clostridium difficile infections, including pseudomembranous colitis, have increased markedly. However, there are few effective treatments for refractory or recurrent C. difficile infections and the outcomes are poor. Fecal microbiota transplantation is becoming increasingly accepted as an effective and safe intervention in patients with recurrent disease, likely due to the restoration of a disrupted microbiome. Cure rates of >90% are being consistently reported from multiple centers. We cured a case of severe refractory C. difficile infection with fecal microbiota transplantation in a patient colonized by vancomycin-resistant enterococcus.

Keywords

Cited by

  1. Can Fecal Microbiota Transplantation (FMT) Eradicate Fecal Colonization With Vancomycin-Resistant Enterococci (VRE)? vol.37, pp.12, 2015, https://doi.org/10.1017/ice.2016.229
  2. Mechanisms of antimicrobial resistance among hospital-associated pathogens vol.16, pp.4, 2015, https://doi.org/10.1080/14787210.2018.1456919
  3. Intestinal microbiota and antibiotic resistance: Perspectives and solutions vol.9, pp.None, 2015, https://doi.org/10.1016/j.humic.2018.05.002
  4. Design and application of oral colon administration system vol.34, pp.1, 2015, https://doi.org/10.1080/14756366.2019.1655406
  5. Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention vol.13, pp.1, 2015, https://doi.org/10.5009/gnl18071
  6. Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives vol.10, pp.None, 2015, https://doi.org/10.3389/fmicb.2019.01704
  7. Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review vol.25, pp.8, 2015, https://doi.org/10.1016/j.cmi.2019.04.006
  8. Efficacy and safety of fecal microbiota transplantation for decolonization of intestinal multidrug-resistant microorganism carriage: beyond Clostridioides difficile infection vol.51, pp.7, 2015, https://doi.org/10.1080/07853890.2019.1662477
  9. The Intestinal Microbiota as a Reservoir and a Therapeutic Target to Fight Multi-Drug-Resistant Bacteria: A Narrative Review of the Literature vol.8, pp.4, 2015, https://doi.org/10.1007/s40121-019-00272-7
  10. Fecal microbiota transplantation for antibiotic resistant bacteria decolonization vol.16, pp.None, 2015, https://doi.org/10.1016/j.humic.2020.100071
  11. Colonization Dynamics of Multidrug-Resistant Klebsiella pneumoniae Are Dictated by Microbiota-Cluster Group Behavior over Individual Antibiotic Susceptibility: A Metataxonomic Analysis vol.10, pp.3, 2021, https://doi.org/10.3390/antibiotics10030268
  12. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis vol.78, pp.15, 2015, https://doi.org/10.1093/ajhp/zxab161